Position in VCEL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$15,133,440
-$9,991,561 QoQ
Shares Held
470,421
-32.6% QoQ
Ownership
0.921%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 91.3877144090081.ToString("F0")%
Shared 0.ToString("F0")%
None 8.612285590991899.ToString("F0")%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,438,935,225 across 518 Biotechnology names. VCEL ranks #111 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in VCEL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,133,440 | 470,421 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $25,125,001 | 697,723 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $17,363,915 | 551,761 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $19,913,907 | 468,012 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $25,301,991 | 567,055 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $29,109,763 | 530,136 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $21,310,896 | 504,400 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $20,892,187 | 455,366 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $23,838,680 | 458,260 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $46,216,292 | 1,297,846 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $45,467,396 | 1,356,426 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $24,952,713 | 664,166 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $16,600,421 | 566,181 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $27,050,123 | 1,026,960 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $34,527,141 | 1,488,239 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $42,143,334 | 1,673,683 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $25,045,181 | 655,290 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $11,155,026 | 283,843 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $13,909,803 | 285,037 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $15,631,138 | 297,736 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $17,201,055 | 309,650 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $6,638,056 | 214,963 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $560,179 | 30,231 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,886,981 | 136,540 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $400,903 | 43,719 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||